Lowering the risk of OHSS : the extended use of antagonist and Cabergoline
Lowering the risk of OHSS: the extended use of antagonist and Cabergoline We are aware that mild to moderate OHSS can occur, even with the agonist trigger. Can we further reduce discomfort and the risk of OHSS?
Our clinics are currently open and operating as normal and we are employing careful COVID related processes as we have since the start of the pandemic.
The safety of our patients and team remains of paramount importance and we continue to operate with social distancing and additional cleanliness measures in place. Video consultations are available for those who prefer not to travel. We also are holding regular open evenings on Eventbrite, please ask our team for details.
We ask all patients to respect government advice and not to travel to the clinic if you are experiencing symptoms or have been asked to self isolate.